SG10201503080XA - Eif4e binding peptides - Google Patents
Eif4e binding peptidesInfo
- Publication number
- SG10201503080XA SG10201503080XA SG10201503080XA SG10201503080XA SG10201503080XA SG 10201503080X A SG10201503080X A SG 10201503080XA SG 10201503080X A SG10201503080X A SG 10201503080XA SG 10201503080X A SG10201503080X A SG 10201503080XA SG 10201503080X A SG10201503080X A SG 10201503080XA
- Authority
- SG
- Singapore
- Prior art keywords
- binding peptides
- eif4e binding
- eif4e
- peptides
- binding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32843710P | 2010-04-27 | 2010-04-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201503080XA true SG10201503080XA (en) | 2015-06-29 |
Family
ID=44861796
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201503080XA SG10201503080XA (en) | 2010-04-27 | 2011-04-27 | Eif4e binding peptides |
SG2012076261A SG184860A1 (en) | 2010-04-27 | 2011-04-27 | Eif4e binding peptides |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012076261A SG184860A1 (en) | 2010-04-27 | 2011-04-27 | Eif4e binding peptides |
Country Status (4)
Country | Link |
---|---|
US (2) | US9018348B2 (de) |
EP (1) | EP2569327B1 (de) |
SG (2) | SG10201503080XA (de) |
WO (1) | WO2011136744A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104411715A (zh) * | 2012-07-09 | 2015-03-11 | 霍夫曼-拉罗奇有限公司 | 靶向eIF4E的细胞穿透肽 |
CN105263950A (zh) * | 2013-03-21 | 2016-01-20 | 新加坡科技研究局 | 钉合eIF4E相互作用肽 |
EP3947416A4 (de) * | 2019-03-29 | 2023-05-31 | Agency for Science, Technology and Research | Peptide und verbindungen, die an den elongationsinitiationsfaktor 4e binden |
TW202114681A (zh) | 2019-07-02 | 2021-04-16 | 美商eFFECTOR醫療公司 | 轉譯抑制劑及其用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE135370T1 (de) | 1988-12-22 | 1996-03-15 | Kirin Amgen Inc | Chemisch modifizierte granulocytenkolonie erregender faktor |
US5324844A (en) | 1989-04-19 | 1994-06-28 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
WO1995000162A1 (en) | 1993-06-21 | 1995-01-05 | Enzon, Inc. | Site specific synthesis of conjugated peptides |
US5880131A (en) | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5965566A (en) | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US6380161B1 (en) * | 1999-06-21 | 2002-04-30 | Inkine Pharmaceutical Company, Inc. | Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions |
GB9914480D0 (en) * | 1999-06-21 | 1999-08-18 | Univ Dundee | Use of peptides |
WO2003057235A2 (en) | 2002-01-10 | 2003-07-17 | Imperial College Innovations Ltd | Modification of feeding behavior |
SG159387A1 (en) | 2002-11-26 | 2010-03-30 | Biocon Ltd In | Modified natriuretic compounds, conjugates, and uses thereof |
EP1668130A2 (de) * | 2003-09-18 | 2006-06-14 | Isis Pharmaceuticals, Inc. | Modulation der eif4e-expression |
-
2011
- 2011-04-27 US US13/695,011 patent/US9018348B2/en active Active
- 2011-04-27 SG SG10201503080XA patent/SG10201503080XA/en unknown
- 2011-04-27 EP EP11775390.5A patent/EP2569327B1/de active Active
- 2011-04-27 SG SG2012076261A patent/SG184860A1/en unknown
- 2011-04-27 WO PCT/SG2011/000165 patent/WO2011136744A1/en active Application Filing
-
2015
- 2015-03-31 US US14/675,675 patent/US9533023B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9533023B2 (en) | 2017-01-03 |
EP2569327A4 (de) | 2013-12-18 |
EP2569327A1 (de) | 2013-03-20 |
EP2569327B1 (de) | 2016-05-25 |
US20130130989A1 (en) | 2013-05-23 |
US20160038567A1 (en) | 2016-02-11 |
US9018348B2 (en) | 2015-04-28 |
SG184860A1 (en) | 2012-11-29 |
WO2011136744A1 (en) | 2011-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20191852T8 (hr) | Polipeptidi | |
IL222323A0 (en) | Tnf - alpha binding proteins | |
HK1182719A1 (en) | Polypeptides | |
IL222980A0 (en) | Il-1 binding proteins | |
ZA201300975B (en) | Binding proteins for hepcidin | |
EP2588129A4 (de) | Auf kleine moleküle zielender proteinabbau | |
ZA201205624B (en) | Cd127 binding proteins | |
GB201012651D0 (en) | Peptides | |
EP2550578A4 (de) | Assoziierte datei | |
IL226157A0 (en) | Antigen binding proteins | |
EP2569338A4 (de) | Bindungssysteme | |
GB201016494D0 (en) | Polypeptide | |
GB201018480D0 (en) | Factors | |
EP2627674A4 (de) | Peptide auf egfr-basis | |
EP2576597A4 (de) | Rhamm-bindende peptide | |
SG10201503080XA (en) | Eif4e binding peptides | |
EP2793918A4 (de) | Hdc-sign-bindende peptide | |
GB201005962D0 (en) | Case folder | |
GB201003906D0 (en) | Binding polypeptides | |
GB201103961D0 (en) | Binding polypeptides | |
TWM400980U (en) | Binding | |
GB201013489D0 (en) | Binding surfaces | |
AU2010057V (en) | Fernside Glycine max | |
GB201010143D0 (en) | Comb binding | |
TWM389093U (en) | Binding device |